Cargando…
Incidence of myopericarditis after mRNA COVID-19 vaccination: A meta-analysis with focus on adolescents aged 12–17 years
BACKGROUND: The incidence of myopericarditis after mRNA COVID-19 vaccination among adolescents aged 12–17 years remains unknown. Therefore, we conducted a study to pool the incidence of myopericarditis following COVID-19 vaccination in this age group. METHODS: We did a meta-analysis by searching 4 e...
Autores principales: | Guo, Bao-Qiang, Li, Hong-Bin, Yang, Li-Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201323/ https://www.ncbi.nlm.nih.gov/pubmed/37246067 http://dx.doi.org/10.1016/j.vaccine.2023.05.049 |
Ejemplares similares
-
COVID‐19 mRNA vaccines and myopericarditis
por: Gnanenthiran, Sonali R., et al.
Publicado: (2022) -
Myocarditis and myopericarditis cases following COVID-19 mRNA vaccines administered to 12–17-year olds in Victoria, Australia
por: Cheng, Daryl R, et al.
Publicado: (2022) -
Important Insights into Myopericarditis after the Pfizer mRNA COVID-19 Vaccination in Adolescents
por: Long, Sarah S.
Publicado: (2021) -
Recurrence of Myopericarditis Following mRNA COVID-19 Vaccination in a Male Adolescent
por: Umei, Tomohiko C., et al.
Publicado: (2021) -
mRNA Coronavirus Disease 2019 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study
por: Kohli, Utkarsh, et al.
Publicado: (2022)